Follow The Filings

CDRE Cadre Holdings Inc.

Health Care, filed as CADRE HLDGS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $8.7M
  • 1 new

In 2026 Q2 First Eagle Investment Management opened a position in Cadre.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... New 0.01%

Who owns CDRE

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.01% New 0.01% 306,458 $8.7M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CDRE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CDRE insider trades
  • None no insider bought on the open market
  • $79.9M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Warren B Kanders CEO
    Sale
    $6.5M 200,000 shares at $32.61
    Traded Aug 24–25 Filed Aug 26
    ↗
  2. Brad Williams President
    Sale
    $2.9M 88,742 shares at $33.24 58% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  3. Warren B Kanders CEO
    Sale
    $2.1M 75,000 shares at $27.57
    Traded Jun 18–22 Filed Jun 23
    ↗
  4. Warren B Kanders CEO
    Sale
    $6.5M 225,000 shares at $29.06
    Traded Jun 15–17 Filed Jun 17
    ↗
  5. Warren B Kanders CEO
    Sale
    $6.3M 200,000 shares at $31.67
    Traded Mar 20–23 Filed Mar 24
    ↗
  6. Blaine Browers CFO
    Sale
    $895K 20,435 shares at $43.79 25% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
    ↗
  7. Brad Williams President
    Sale
    $1M 24,000 shares at $42.99 31% of stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
    ↗
  8. Warren B Kanders CEO
    Sale
    $52.4M 1,343,941 shares at $39.00
    Traded Nov 17, 2025 Filed Nov 19, 2025
    ↗
  9. Brad Williams President
    Sale
    $1.2M 27,370 shares at $43.62 26% of stake
    Traded Nov 13, 2025 Filed Nov 17, 2025
    ↗
  10. Brad Williams President
    Planned sale
    $178K 4,132 shares at $43.00 3.7% of stake
    Traded Oct 24, 2025 Filed Oct 28, 2025
    ↗
  11. Brad Williams President
    Planned sale
    $165K 4,132 shares at $40.00 3.6% of stake
    Traded Oct 14, 2025 Filed Oct 16, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 option exercises, 10 share withholdings for taxes, and 1 gift.

Congress

2 members of Congress traded CDRE in the last three years: 5 buys and 2 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jun 30 filed Jul 2
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Mar 16 filed Apr 7
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jun 11, 2025 filed Jul 10, 2025
  4. Josh Gottheimer D-NJ-5Joint Sell $1K–$15K Apr 17, 2025 filed May 14, 2025
  5. Josh Gottheimer D-NJ-5Joint Buy $1K–$15K Jan 27, 2025 filed Feb 10, 2025
  6. Josh Gottheimer D-NJ-5Joint Sell $1K–$15K Dec 27, 2024 filed Jan 14, 2025

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K/A 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.02,5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $482.53M $567.56M $610.31M
Gross profit $200.73M $233.48M $259.63M
Gross margin * 41.6% 41.1% 42.5%
Net income $38.64M $36.13M $44.14M
Net margin * 8.0% 6.4% 7.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $245.84M $327.57M $365.87M
Total non-current assets * $185.34M $325.14M $404.16M
Total assets $431.18M $652.71M $770.03M
Total current liabilities $95.21M $94.12M $104.5M
Total non-current liabilities * $138.81M $247.07M $347.73M
Total equity $197.16M $311.52M $317.8M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $73.21M $31.78M $63.7M
Cash from investing -$6.52M -$147.43M -$96.37M
Cash from financing -$24.72M $152.67M $31.59M
Net change in cash $42.4M $37.24M $0.394M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Q2 2026

Period archive

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf